VeriMomspironolactone hamilelikte güvenli mi?
Spironolactone has a harmonised CLP reproductive toxicity classification (H360 — 'May damage fertility or the unborn child') on ECHA records/annex listings, and animal and case-report data support anti‑androgenic effects on fetal sexual development; mechanism is well characterised (anti‑androgenic activity demonstrated in vivo). Topical cosmetic use would usually give low systemic exposure compared with oral therapeutic dosing, so exposure from typical topical cosmetic use is judged low but measurable. Sources: ECHA CLP/harmonised listing, FDA product label, animal/human reports (PubMed/PMC).
Hamilelikte spironolactone yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- spironolactone hamilelikte güvenli mi?
- Spironolactone has a harmonised CLP reproductive toxicity classification (H360 — 'May damage fertility or the unborn child') on ECHA records/annex listings, and animal and case-report data support anti‑androgenic effects on fetal sexual development; mechanism is well characterised (anti‑androgenic activity demonstrated in vivo). Topical cosmetic use would usually give low systemic exposure compared with oral therapeutic dosing, so exposure from typical topical cosmetic use is judged low but measurable. Sources: ECHA CLP/harmonised listing, FDA product label, animal/human reports (PubMed/PMC).
- spironolactone emzirirken güvenli mi?
- Intrinsic hazard remains at H360 level (may damage the unborn child/fertility). Mechanism (anti‑androgenic activity / endocrine effects) is well characterised. Clinical/lactation databases (LactMed, NHS) report low transfer of spironolactone into breast milk and no consistent adverse effects in reported infants at therapeutic maternal doses, so exposure to a breastfed infant from maternal systemic dosing is generally low; for cosmetic topical use systemic levels would be expected to be lower still (low but potentially measurable).
- spironolactone bebek cildi için güvenli mi?
- The substance carries harmonised H360 (intrinsic reproductive hazard) so hazard score is 3. Mechanistic anti‑androgenic activity is well characterised. Exposure for infants (0–3 yr) is higher than adults for a given topical exposure because of immature barrier and higher surface‑area‑to‑weight; therefore exposure score is increased by one compared with adult topical use (adult topical e=1 → infant e=2). There is no infant‑specific evidence to change hazard or mechanism scores.
- VeriMom spironolactone nasıl puanlıyor?
- VeriMom spironolactone'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 13/100 (yüksek risk) olarak puanlar.
- Hamilelikte spironolactone yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.